<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210427051098N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-10-10</date_registration>
      <primary_sponsor>Yazd University of Medical Sciences</primary_sponsor>
      <public_title>The effect of Dietary Approaches to Stop Hypertension diet on mental health</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of Dietary Approaches to Stop Hypertension diet on stress, depression, quality of life and sleep status of students and their families: A randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>400</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/55994</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: After determining the eligible people and obtaining their consent, the participants will be divided into two groups [intervention (DASH diet) or control (standard diet)] by random allocation method. Firstly, each individual will receive a specific code number. Then all code numbers will be entered to random allocation software. Software inputs will include the total number of samples and the number of treatment groups (intervention and control). The software output will include random numbers assigned to two groups. The allocation ratio will be 1:1. Each participant will have an equal chance of being in each group, and participants in the study will not be able to predict the type of intervention they receive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Depression. Condition 2: Anxiety. Condition 3: Sleep disorders. Condition 4: Dyspepsia. Condition 5: Irritable bowel syndrome. Condition 6: Stress. Condition 7: Quality of life.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: in this group, the individuals will receive dietary approach to stop hypertension (DASH) diet which including 18% protein, 27% fat and 55% carbohydrate. At first, the study participants will be trained DASH diet recommendations in four online sessions of 2 hour each. Then, the individuals will weekly receive DASH recommendations through communication software during intervention. The individuals will be encouraged to consume more amount of whole grains, low-fat foods, fish, chicken, lean beef and eggs (to reduce the intake of saturated fat and cholesterol), low-fat dairy products, seeds and nuts, fruits and vegetables high in potassium (with emphasis on sources of key nutrients in the DASH diet). We will recommend individuals to limit intake of processed foods, which have high calorie density and are rich in fats, sugars and sodium. Sodium intake will be limited to 2,400-3,000 mg/day. The required energy of each person will be determined based on Harris Benedict formula. If a person is overweight or obese, the patient's calculated energy will be reduced by 500 kcal. The dietary plan will prescribe individually. The duration of the study and intervention will be 6 months. Training sessions will be held once a week in the first month. Contents of the first session: Principles of DASH diet and calculation of calorie intake, Session 2:  Carbohydrate sources of DASH diet, Session 3: Protein sources of DASH diet, Fourth session: Fat sources of DASH diet and sodium and sugar restriction of diet. Intervention 2: Control group: In this group, the individuals will receive standard diet which including 15% protein, 30% fat and 55% carbohydrate. At first, the study participants will be trained standard diet recommendations in four online sessions of 2 hour each. Then, the individuals will weekly receive standard diet recommendations through communication software during intervention. The amount of calories is the same as the intervention group, but differs from the intervention group in terms of the number of food group units. Diet low in sugar and fat will be recommended. We will not have any recommendation about sodium or potassium intakes. The required energy of each person will be determined based on Harris Benedict formula. If a person is overweight or obese, the patient's calculated energy will be reduced by 500 kcal. The dietary plan will prescribe individually. Contents of the first session: Food groups and calculation of calorie intake, Session 2:  Importance of cereals, legumes and sugar in diet, Session 3: the role of dairy products, meat and oil in human health, Fourth session: importance of fruits and vegetables in human health.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
primary outcome will be available at the end of study

When:
From January 2023

To whom:
Academic institutions

Conditions:
Academic institutes can send their official request to the email of the scientific director of the project. the data will be sent after confirmation of ethics committee of shahid sadoughi university of medical sciences. It is not possible to perform statistical analysis on the data.

Where to obtain:
Sayyed Saeid Khayyatzadeh
Assistant professor of nutrition in Shahid Sadoughi university of medical sciences
Khayyatzadeh@yahoo.com
00983538209100

How to obtain:
Academic institutes can send their official request to the email of the scientific director of the project. The data will be sent after confirmation of ethics committee of Shahid Sadoughi university of medical sciences

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sayyed Saeid Khayyatzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Sadoughi University of Medical Sciences, Alem Square.</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8915173160</zip>
        <telephone>+98 35 3820 9100</telephone>
        <email>khayyatzadeh@yahoo.com</email>
        <affiliation>Shahid Sadoughi University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyed Saeed Khayatzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Nutrition, Faculty of Public Health, Shahid Sadughi University of Medical Sciences, Alem Square.</address>
        <city>yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8915173160</zip>
        <telephone>+98 35 3820 9100</telephone>
        <email>khayyatzadeh@yahoo.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Undergraduate nutrition students and their families (over 12 years old)
Completion of informed consent</inclusion_criteria>
      <agemin>12 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnancy and lactation
Suffering from cancer
Suffering from autoimmune diseases
Suffering from inflammatory bowel disease
Chronic or acute kidney disease (creatinine ≥ 1.4 mg / dL for men or ≥ 1.3 for women or proteinuria)
Hospitalization for more than 2 weeks</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F06.31</hc_code>
      <hc_code>F06.4</hc_code>
      <hc_code>F51</hc_code>
      <hc_code>K30</hc_code>
      <hc_code>K58</hc_code>
      <hc_code>F54</hc_code>
      <hc_code>F54</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Mood disorder due to known physiological condition with depressive features</hc_keyword>
      <hc_keyword>Anxiety disorder due to known physiological condition</hc_keyword>
      <hc_keyword>Sleep disorders not due to a substance or known physiological condition</hc_keyword>
      <hc_keyword>Functional dyspepsia</hc_keyword>
      <hc_keyword>Irritable bowel syndrome</hc_keyword>
      <hc_keyword>Psychological and behavioral factors associated with disorders or diseases classified elsewhere</hc_keyword>
      <hc_keyword>Psychological and behavioral factors associated with disorders or diseases classified elsewhere</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: in this group, the individuals will receive dietary approach to stop hypertension (DASH) diet which including 18% protein, 27% fat and 55% carbohydrate. At first, the study participants will be trained DASH diet recommendations in four online sessions of 2 hour each. Then, the individuals will weekly receive DASH recommendations through communication software during intervention. The individuals will be encouraged to consume more amount of whole grains, low-fat foods, fish, chicken, lean beef and eggs (to reduce the intake of saturated fat and cholesterol), low-fat dairy products, seeds and nuts, fruits and vegetables high in potassium (with emphasis on sources of key nutrients in the DASH diet). We will recommend individuals to limit intake of processed foods, which have high calorie density and are rich in fats, sugars and sodium. Sodium intake will be limited to 2,400-3,000 mg/day. The required energy of each person will be determined based on Harris Benedict formula. If a person is overweight or obese, the patient's calculated energy will be reduced by 500 kcal. The dietary plan will prescribe individually. The duration of the study and intervention will be 6 months. Training sessions will be held once a week in the first month. Contents of the first session: Principles of DASH diet and calculation of calorie intake, Session 2:  Carbohydrate sources of DASH diet, Session 3: Protein sources of DASH diet, Fourth session: Fat sources of DASH diet and sodium and sugar restriction of diet.</i_keyword>
      <i_keyword>Control group: In this group, the individuals will receive standard diet which including 15% protein, 30% fat and 55% carbohydrate. At first, the study participants will be trained standard diet recommendations in four online sessions of 2 hour each. Then, the individuals will weekly receive standard diet recommendations through communication software during intervention. The amount of calories is the same as the intervention group, but differs from the intervention group in terms of the number of food group units. Diet low in sugar and fat will be recommended. We will not have any recommendation about sodium or potassium intakes. The required energy of each person will be determined based on Harris Benedict formula. If a person is overweight or obese, the patient's calculated energy will be reduced by 500 kcal. The dietary plan will prescribe individually. Contents of the first session: Food groups and calculation of calorie intake, Session 2:  Importance of cereals, legumes and sugar in diet, Session 3: the role of dairy products, meat and oil in human health, Fourth session: importance of fruits and vegetables in human health.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety. Timepoint: Before the intervention, 6 months after the intervention. Method of measurement: DASS-21 validated questionnaire.</prim_outcome>
      <prim_outcome>Depression. Timepoint: Before the intervention, 6 months after the intervention. Method of measurement: Beck and DASS-21 validated questionnaires.</prim_outcome>
      <prim_outcome>Sleep quality. Timepoint: Before the intervention, 6 months after the intervention. Method of measurement: Pittsburgh Validated Questionnaire.</prim_outcome>
      <prim_outcome>Stress. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: DASS-21 validated questionnaire.</prim_outcome>
      <prim_outcome>Quality of life. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: SF-12 validated questionnaire.</prim_outcome>
      <prim_outcome>Excessive daytime sleepiness. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: Epworth Sleepiness Scale validated questionnaire.</prim_outcome>
      <prim_outcome>Dyspepsia. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: Rome IV questionnaire.</prim_outcome>
      <prim_outcome>Irritable bowel syndrome. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: Rome IV questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Weight. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: Weighting scale.</sec_outcome>
      <sec_outcome>Body mass index (BMI). Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: Ratio of weight to height squared.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yazd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-02-03</approval_date>
        <contact_name>Ethics Committee of Shahid Sadoughi University of Medical Sciences, Yazd</contact_name>
        <contact_address>Central Building of Shahid Sadoughi University of Medical Sciences, Yazd, Bahonar Square, Shahid Sadoughi Blvd Yazd Yazd Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
